Table 1 Characteristics of study participants at baseline
Control n (%) | RHB n (%) | RHBM n (%) | |
|---|---|---|---|
Number of subjects | 23 (32.4) | 22 (31) | 26 (36.6) |
Sex | |||
Female | 4 (17.4) | 4 (18.2) | 5 (19.2) |
Male | 19 (82.6) | 18 (81.8) | 21 (80.8) |
Working | |||
Yes | 5 (22.7) | 6 (27.3) | 7 (26.9) |
Smoking habits | |||
Smoker | 8 (34.8) | 7 (31.8) | 9 (34.6) |
Never smoked | 2 (8.7) | 0 (0.0) | 1 (3.8) |
Ex-smoker | 13 (56.5) | 15 (68.2) | 16 (61.5) |
MRCs dyspnea score category | |||
0 | 11 (47.8) | 7 (31.8) | 4 (15.4) |
1 | 11 (47.8) | 11 (50.0) | 17 (65.4) |
2 | 1 (4.3) | 2 (9.1) | 5 (19.2) |
3 | 0 (0.0) | 1 (4.5) | 0 (0.0) |
4 | 0 (0.0) | 1 (4.5) | 0 (0.0) |
Lag time enrolment to basal/ evaluation (days), mean (SD) | 87.4 (85.1) | 110.1 (103.2) | 93.8 (89.5) |
Age (years), mean (95%CI) | 63.4 (60.4-66.4) | 64.1 (59.9-68.2) | 64.9 (62.1-67.7) |
Body Mass Index, mean (95%CI) | 28.4 (26.3-30.5) | 27.6 (25.4-29.9) | 29.8 (27.8-31.7) |
CRQ, mean (95%CI) | |||
Fatigue | 5.7 (5.2-6.2) | 5.3 (4.8-5.7) | 5.2 (4.6-5.8) |
Mastery | 6.3 (5.7-7.0) | 7.2 (6.3-8.1) | 7.2 (6.2-8.2) |
Dyspnea | 2.5 (1.8-3.1) | 3.0 (2.5-3.6) | 3.0 (2.4-3.5) |
Emotion | 5.2 (4.6-5.8) | 4.6 (4.0-5.3) | 4.2 (3.6-4.8) |
Pulmonary function mean (95%CI) | |||
FVC (l) | 74.0 (66.5-81.5) | 73.7 (66.4-81.0) | 73.4 (67.2-79.6) |
FEV1 (l) | 60.1 (55.6-64.4) | 59.9 (54.9-64.8) | 60.9 (56.3-65.5) |
FEV1/FVC | 59.1 (54.5-63.1) | 60.8 (56.5-65.1) | 61.2 (58.6-63.8) |
Walking test (m), mean (95%CI) | 436.2 (402.8-469.6) | 466.7 (432.0-501.5) | 450.7 (413.4 -488.1) |
COPD exacerbation hospitalization | |||
Yes n (%) | 5 (21.7) | 5 (22.7) | 3 (11.5) |
mean (95%CI) | 0.6 (0.01-1.2) | 0.8 (−0.1-1.8) | 1.2 (0.21-2.19) |
COPD exacerbation visit to family physician | |||
Yes n (%) | 12 (52.2) | 9 (40.9) | 7 (28) |
mean (95%CI) | 3 (−2.4-8.4) | 0.5 (−0.01-0.9) | 0.5 (−0.04-0.9) |
COPD treatment with antibiotics or corticoids | |||
Yes n (%) | 11 (50) | 8 (36.4) | 9 (36) |
mean (95%CI) | 0.6 (0.01-1.2) | 0.8 (−0.1-1.7) | 1.2 (0.2-2.2) |